SERPINE1 and cardiovascular disorder: Plasminogen activator inhibitor-1 (PAI-1), a novel target for the clinical treatment of cardiovascular disease (4), inhibits fibrinolysis, induces barriers for extracellular matrix degradation, impacts the invasiveness of cells (5) and plays an important role in vascular structural and functional changes (6).